Dong Wei

1.0k total citations · 1 hit paper
25 papers, 535 citations indexed

About

Dong Wei is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Dong Wei has authored 25 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Dong Wei's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (5 papers) and Respiratory viral infections research (4 papers). Dong Wei is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (5 papers) and Respiratory viral infections research (4 papers). Dong Wei collaborates with scholars based in China and France. Dong Wei's co-authors include Xinxin Zhang, Jieming Qu, Lingxi Guo, Min Zhou, Yurong Wu, Qing Yun Li, Xiaoqi Yu, Donghua Zhang, Mingjie Wang and Feng Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Genome biology.

In The Last Decade

Dong Wei

24 papers receiving 523 citations

Hit Papers

Clinical Features Predicting Mortality Risk in Patients W... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Wei China 10 331 133 113 69 67 25 535
Xingxiang Yang China 8 240 0.7× 96 0.7× 36 0.3× 70 1.0× 39 0.6× 14 429
Pei Hua Lee Singapore 7 401 1.2× 69 0.5× 67 0.6× 41 0.6× 54 0.8× 13 515
Negar Niki Alami United States 7 342 1.0× 135 1.0× 84 0.7× 19 0.3× 37 0.6× 14 460
Jaap van Dissel Netherlands 9 427 1.3× 227 1.7× 76 0.7× 66 1.0× 133 2.0× 13 660
Juan Esteban Gallo Colombia 9 429 1.3× 151 1.1× 143 1.3× 96 1.4× 31 0.5× 21 665
David Morquin France 11 282 0.9× 121 0.9× 46 0.4× 41 0.6× 23 0.3× 47 474
Xiaojian Cui China 9 358 1.1× 110 0.8× 70 0.6× 67 1.0× 49 0.7× 13 597
Annalisa Mondi Italy 9 254 0.8× 66 0.5× 52 0.5× 36 0.5× 32 0.5× 26 380
Bandar Alosaimi Saudi Arabia 13 306 0.9× 146 1.1× 87 0.8× 85 1.2× 44 0.7× 45 524

Countries citing papers authored by Dong Wei

Since Specialization
Citations

This map shows the geographic impact of Dong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Wei more than expected).

Fields of papers citing papers by Dong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Wei. The network helps show where Dong Wei may publish in the future.

Co-authorship network of co-authors of Dong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Wei. A scholar is included among the top collaborators of Dong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Wei. Dong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Li, Dong Wei, Shiyu Song, et al.. (2025). Restoring Muribaculum intestinale –Derived Butyrate Mitigates Skeletal Muscle Loss in Cancer Cachexia. Journal of Cachexia Sarcopenia and Muscle. 16(6). e70140–e70140.
2.
Yang, Xiaoxu, Dong Wei, Xin Wang, et al.. (2025). BCG-trained macrophages couple LDLR upregulation to type I IFN responses and antiviral immunity. Cell Reports. 44(4). 115493–115493. 2 indexed citations
3.
Chen, Ning, et al.. (2024). A novel inertial parameter identification method for the ship-mounted Stewart platform based on a wave compensation platform. Measurement. 242. 116010–116010. 2 indexed citations
4.
Ashraf, Muhammad Awais, et al.. (2024). A comprehensive review of influenza B virus, its biological and clinical aspects. Frontiers in Microbiology. 15. 1467029–1467029. 7 indexed citations
5.
Wang, Jing, Muhammad Awais Ashraf, Muhammad Asif Raza, et al.. (2024). Evolutionary trends of respiratory syncytial viruses: Insights from large-scale surveillance and molecular dynamics of G glycoprotein. Heliyon. 10(10). e30886–e30886. 1 indexed citations
6.
Xu, Huiting, et al.. (2023). The Research Progress on Immortalization of Human B Cells. Microorganisms. 11(12). 2936–2936. 1 indexed citations
7.
Wei, Dong, Yingying Chen, Xiaoqi Yu, et al.. (2022). Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccination. Emerging Microbes & Infections. 11(1). 2474–2484. 2 indexed citations
8.
Yu, Xiaoqi, Dong Wei, Wentian Guo, et al.. (2022). Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern. Nature Communications. 13(1). 1788–1788. 28 indexed citations
9.
Li, Jing, Lihong Qu, Xuehua Sun, et al.. (2021). Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients. Journal of Viral Hepatitis. 28(10). 1381–1391. 8 indexed citations
10.
Mei, Hong, Wei Wang, Yusang Xie, et al.. (2021). Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist. Genome biology. 22(1). 297–297. 10 indexed citations
11.
Yu, Shanhe, Caixia Di, Shijun Chen, et al.. (2021). Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects. Cell Research. 31(11). 1148–1162. 17 indexed citations
12.
Liu, Tingting, Jing Dai, Zhitao Yang, et al.. (2021). Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort. Science Bulletin. 66(22). 2312–2319. 20 indexed citations
13.
Ye, Fei, Wei Huang, Yuan Xue, et al.. (2021). Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection. SHILAP Revista de lepidopterología. Volume 8. 285–300. 4 indexed citations
14.
Yu, Xiaoqi, Dong Wei, Yongyan Chen, Donghua Zhang, & Xinxin Zhang. (2020). Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness. Emerging Microbes & Infections. 9(1). 1470–1473. 6 indexed citations
15.
Chen, Yingying, et al.. (2020). Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays. Cell Discovery. 6(1). 75–75. 20 indexed citations
16.
Guo, Lingxi, Dong Wei, Xinxin Zhang, et al.. (2019). Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score. Frontiers in Microbiology. 10. 2752–2752. 280 indexed citations breakdown →
17.
Wei, Dong, et al.. (2018). The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine. Biotechnology Letters. 40(8). 1263–1270. 1 indexed citations
18.
Wei, Dong, Mingjie Wang, Donghua Zhang, et al.. (2018). Genome-wide characterization of the seasonal H3N2 virus in Shanghai reveals natural temperature-sensitive strains conferred by the I668V mutation in the PA subunit. Emerging Microbes & Infections. 7(1). 1–15. 9 indexed citations
20.
Li, Yuqin, Xuewu Zhang, Gu Chen, Dong Wei, & Feng Chen. (2008). Algal Lectins for Potential Prevention of HIV Transmission. Current Medicinal Chemistry. 15(11). 1096–1104. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026